ANZAC: A NEOADJUVANT BIOMARKER STUDY EXPLORING THE ANTI-TUMOUR ACTIVITY OF THE ADDITION OF ZOLEDRONIC ACID TO CHEMOTHERAPY IN BREAST CANCER

被引：0
|
作者：
Winter, M. C.
Cross, S. S. [1 ]
Ingram, C. E. [2 ]
Jolley, I. J. [2 ]
Holen, I. [3 ]
Hatton, M. Q. [4 ]
Horsman, J. M.
Coleman, R. [5 ]
机构：
[1] Univ Sheffield, Royal Hallamshire Hosp, Acad Unit Pathol, Sheffield S10 2JF, S Yorkshire, England
[2] Sheffield Teaching Hosp, NHS Fdn Trust, Royal Hallamshire Hosp, Dept Radiol, Sheffield, S Yorkshire, England
[3] Univ Sheffield, Acad Unit Clin Oncol, Bone Oncol Labs, Sheffield, S Yorkshire, England
[4] Sheffield Teaching Hosp, NHS Fdn Trust, Weston Pk Hosp, Dept Clin Oncol, Sheffield, S Yorkshire, England
[5] Weston Pk Hosp, Canc Res Ctr, Sheffield, S Yorkshire, England
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [31] Proof of the Anti-Tumour Effect of Zoledronic Acid (ZA) in Naive Bone-Only Metastatic and Locally Advanced Breast Cancer: Results from the Biological Window Therapy.
    Foroni, C.
    Andreis, D.
    Maldotti, M.
    Cappelletti, M. R.
    Generali, D. G.
    [J]. CANCER RESEARCH, 2011, 71
  • [32] Randomized Controlled Trial of Zoledronic Acid plus Chemotherapy versus Chemotherapy Alone as Neoadjuvant Treatment of HER2-Negative Primary Breast Cancer (JONIE Study)
    Hasegawa, Yoshie
    Tanino, Hirokazu
    Horiguchi, Jun
    Miura, Daishu
    Ishikawa, Takashi
    Hayashi, Mitsuhiro
    Takao, Shintaro
    Kim, Seung Jin
    Yamagami, Kazuhiko
    Miyashita, Masaru
    Konishi, Muneharu
    Shigeoka, Yasushi
    Suzuki, Masato
    Taguchi, Tetsuya
    Kubota, Tomoyuki
    Akazawa, Kouhei
    Kohno, Norio
    [J]. PLOS ONE, 2015, 10 (12):
  • [33] Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics
    Tetsuro Yoshimaru
    Keisuke Aihara
    Masato Komatsu
    Yosuke Matsushita
    Yasumasa Okazaki
    Shinya Toyokuni
    Junko Honda
    Mitsunori Sasa
    Yasuo Miyoshi
    Akira Otaka
    Toyomasa Katagiri
    [J]. Scientific Reports, 7
  • [34] Influence of Zoledronic Acid on BMD in Premenopausal Women with Breast Cancer and Neoadjuvant or Adjuvant Chemotherapy and/or Endocrine Treatment - The ProBone Studies.
    Hadji, P.
    Kauka, A.
    Bauer, T.
    Kalder, M.
    Albert, U.
    Birkholz, K.
    Baier, M.
    Muth, M.
    Ziller, M.
    [J]. CANCER RESEARCH, 2011, 71
  • [35] Measuring cfDNA integrity as a biomarker for predicting neoadjuvant chemotherapy response in breast cancer patients: a pilot study
    Giro, Camila
    Yamada, Alayne M. T. D.
    Cruz, Felipe Jose S. M.
    do R. Barros, Lilian A.
    da C. A. Alves, Beatriz
    Fonseca, Fernando L. A.
    del Giglio, Auro
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (02) : 329 - 335
  • [36] Anticancer activity of letrozole plus zoledronic acid as neoadjuvant therapy for postmenopausal patients with breast cancer: FEMZONE trial results
    Fasching, P. A.
    Jud, S. M.
    Hauschild, M.
    Kuemmel, S.
    Schuette, M.
    Warm, M.
    Hanf, V.
    Muth, M.
    Baler, M.
    Schulz-Wendtland, R.
    Beckmann, M. W.
    Lux, M. P.
    [J]. CANCER RESEARCH, 2012, 72
  • [37] Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study
    Buckley, A.
    McQuaid, S.
    Johnson, P.
    Buggy, D. J.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2014, 113 : 56 - 62
  • [38] Catumaxomab Induces Efficient Anti-tumour Activity in Vitro With Immune Cells From Ovarian Cancer Patients After Chemotherapy Treatment
    Braicu, I.
    Atz, J.
    Dettmar, K.
    Martinius, H.
    Spannagl, R.
    Seimetz, D.
    Lindhofer, H.
    Chekerov, R.
    Pietzner, K.
    Sehouli, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S529 - S529
  • [39] Anti-tumour effects of zoledronic acid and somatostatin analogues in murine androgen-independent neuroendocrine carcinoma as hormone-refractory prostate cancer model
    Hashimoto, K.
    Masumori, N.
    Tanaka, T.
    Uchida, K.
    Tsukamoto, T.
    [J]. EJC SUPPLEMENTS, 2010, 8 (05): : 128 - 128
  • [40] The value of tumour infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a study in a hospital complex
    Cordoba, A.
    Ruiz de Azua, Y.
    Arean, C.
    Aguiar, B.
    Nova, L.
    Labiano, T.
    Ulazia, A.
    Guerrero, D.
    [J]. VIRCHOWS ARCHIV, 2018, 473 : S56 - S56
12345